Kimberly Clark CORP 8-K filings

Kimberly-Clark announced second quarter 2026 results with net sales of $4.2 billion, driven by innovation and productivity, while updating its 2026 outlook.

Kimberly-Clark Corporation held its 2026 Annual Meeting of Stockholders, where directors were elected, auditors ratified, and executive compensation approved, though a proposal for an independent Board Chair was not approved.

Kimberly-Clark announced first quarter 2026 results, showing net sales growth and reaffirming its full-year outlook, driven by innovation and productivity.

Kimberly-Clark and Kenvue shareholders overwhelmingly approved all proposals for Kimberly-Clark's acquisition of Kenvue, moving closer to creating a global health and wellness leader.

Kimberly-Clark reported strong fourth-quarter and full-year 2025 results, driven by its transformation strategy and anticipating further momentum from the Kenvue acquisition.

Kimberly-Clark Corporation filed an 8-K to supplement its joint proxy statement/prospectus regarding its merger with Kenvue Inc., addressing multiple stockholder lawsuits alleging material omissions.

Kimberly-Clark Corporation has recast its 2024 financial statements to reflect the International Family Care and Professional (IFP) segment as discontinued operations following a joint venture agreement with Suzano S.A.

Kimberly-Clark Corporation announced the departure of Chief Digital and Technology Officer Zackery Hicks, effective March 31, 2026.

Kimberly-Clark Corporation announced an agreement to acquire Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion, creating a global health and wellness leader.

Kimberly-Clark reports resilient third-quarter 2025 results with 2.5% organic sales growth driven by innovation and volume, while updating its full-year outlook.

Kimberly-Clark announced robust second quarter 2025 results, driven by innovation-led volume growth and effective cost management, leading to an upward revision of its full-year outlook.

Kimberly-Clark Corporation has reclassified its International Family Care and Professional segment as discontinued operations, providing supplemental historical financial data to reflect its strategic joint venture with Suzano S.A.

Kimberly-Clark announced a strategic partnership with Suzano S.A. to form a joint venture for its International Family Care and Professional (IFP) business, receiving approximately $1.7 billion for a 51% stake and sharpening its focus on higher-growth segments.

Kimberly-Clark Corporation will voluntarily transfer its U.S. stock exchange listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market (Nasdaq), effective May 30, 2025.

Kimberly-Clark Corporation discloses long-term incentive awards and compensation details for Andrew Scribner, the newly elected Vice President and Controller, effective June 1, 2025.

Kimberly-Clark Corporation has promoted Russ Torres to President and Chief Operating Officer, effective May 1, 2025, to oversee day-to-day operations and drive global growth.

Kimberly-Clark Corporation held its 2025 Annual Meeting of Stockholders on May 1, 2025, where stockholders elected directors, ratified the selection of Deloitte & Touche LLP as independent auditors, and approved executive compensation.

Kimberly-Clark reports a decrease in net sales for Q1 2025, adjusting its full-year outlook due to potential incremental costs from a more uncertain geopolitical landscape.

Kimberly-Clark Corporation has appointed Andrew Scribner as its new Vice President and Controller, effective June 1, 2025, succeeding Andrew S. Drexler who will retire shortly after.

Kimberly-Clark reported strong 2024 results, exceeding their long-term growth algorithm and establishing a foundation for their Powering Care strategy, with a positive outlook for continued growth in 2025.

Kimberly-Clark Corporation has reorganized its internal structure, shifting from product-based to geographic-based reporting segments to streamline its supply chain and improve efficiency.

Kimberly-Clark Corporation has elected Joseph Romanelli, President of Human Health International for Merck & Co., to its Board of Directors, effective immediately, increasing the board size to thirteen.

Kimberly-Clark's third quarter results show a 1% organic sales growth despite a 4% decrease in net sales, driven by strong in-market execution and cost management.

Kimberly-Clark reported strong second-quarter results, driven by organic sales growth and effective cost management, leading to an increased full-year earnings outlook.

Kimberly-Clark Corporation's stockholders approved an amended certificate of incorporation at the annual meeting, limiting certain officer liability and making technical changes.

Kimberly-Clark reported strong first-quarter 2024 results, driven by organic sales growth and productivity gains, leading to an increased full-year outlook.

Kimberly-Clark is initiating a global transformation to streamline operations, targeting significant cost savings and growth through a new operating model.

Kimberly-Clark Corporation has announced the appointment of Grant McGee as Senior Vice President and General Counsel, effective February 1, 2024, while Jeff Melucci expands his role to Chief Business and Transformation Officer.

Kimberly-Clark exceeded expectations in 2023 with strong organic sales growth and improved cost recovery, and anticipates continued momentum into 2024.